Gene Query: AHNAK2

Dataset Description Geneva Score
Gene expression analysis of the impact of TDP-43 knockout in human cells. 134.23
H1609088 Human RNA-Sequencing 123.21
Rorc disruption in human FG pancreatic cancer cells 112.14
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 108.05
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 107.4
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 107.4
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 100.43
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 96.28
PNET animal model: new insights (II) 94.68
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 85.43
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 83.31
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 81.25
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 75.42
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 73.63
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 72.98
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 72.49
Hypoxic transcriptome of SQ20B human head and neck cancer cells 71.05
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 69.77
Genome-wide functional assessment of enhancer activities in the human genome 69.01
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 68.11
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 66.85
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 66.81
Nutritional control of protein translation 64.73
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 62.64
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 62.27
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 61.83
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 61.18
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 61.18
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 59.85
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 58.55
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 58.55
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 57.42
Depicting early human development and germ cell origin with porcine embryos 57.16
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 56.38
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 56.37
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 55.6
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 55.53
Patient-derived luminal breast cancer xenografts with progestins 55.16
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 55.16
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 55.07
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 53.27
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 53.13
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 53.13
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 52.21
Cajal bodies are linked to genome conformation [RNA-Seq] 52.08
Cajal bodies are linked to genome conformation 52.08
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 52.01
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 51.99
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 51.28
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 50.98
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 50.65
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 49.77
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 48.52
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 48.41
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 47.39
GATA3-mediated chromatin reprogramming in breast cancer cells 47.29
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 46.93
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 46.72
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 46.71
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 46.47
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 46.47
CHCHD2 gene KO effect in iPSC drived motor neurons 46.09
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 46.01
G-quadruplex structures mark human regulatory chromatin 45.86
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 45.43
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 45.41
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 45.0
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 44.72
Transcriptomic analysis of ERR alpha orphan nuclear receptor 44.3
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 44.24
DJ-1 is dispensable for human stem cell homeostasis 44.17
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 43.9
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 43.9
A prostate cancer chromatin interaction map 43.41
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 42.84
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 42.04
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 41.82
FOXP1 orchestration of ASD-relevant signaling pathways. 41.75
The effect of PPARG inhibition on human angiomyolipoma cells 41.22
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 40.78
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 40.78
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 40.51
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 40.51
Transcriptome profiling of Normal and Cancerous Prostate Cells 40.37
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 40.29
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 40.15
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 40.02
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 40.02
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 39.68
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 39.42
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 39.07
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 39.02
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 38.86
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 38.63
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 38.28
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 38.23
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 37.66
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 37.62
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 37.62
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 37.44
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 37.35
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 36.97
NHLRC1 re-expression in cancer cells 35.96
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 35.83
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 35.79
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 35.75
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 35.72
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 34.96
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 34.76
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 34.76
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 34.55
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 34.13
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 34.02
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 33.55
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 33.13
Integrin signaling regulates YAP/TAZ to control skin homeostasis 32.79
BET bromodomain inhibition 32.6
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 32.6
Lipid degradation promotes prostate cancer cell survival 32.59
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 32.45
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 32.45
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 32.37
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 32.21
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 32.15
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 32.04
MYCi975 regulates MYC target genes 32.02
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 31.6
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 31.5
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 31.4
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 31.28
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 31.22
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 30.3
Regionally specified human pluripotent stem cell-derived astrocytes 30.3
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 29.83
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 29.71
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 29.66
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 29.58
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 29.49
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 29.46
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 29.45
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 29.4
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 29.36
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 29.24
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 29.18
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 29.17
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 29.17
The regulartory role of ZCCHC24 in splicing machinery 29.06
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 29.01
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 28.69
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 28.57
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 28.45
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 28.43
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 28.29
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 27.99
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 27.87
Disruption of the exocyst induces podocyte loss and dysfunction 27.67
The cohesin complex prevents Myc-induced replication stress 27.63
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 27.63
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 27.29
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 27.19
Effect of Influenza virus infection on lncRNA expression in A549 cells 26.96
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 26.96
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 26.79
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 26.73
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 26.65
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 26.65
Fibroblasts in cholesteatoma activate osteoclasts. 26.63
EP400 is required for Max and MCPyV mediated gene activation 26.56
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 26.53
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 26.49
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 26.46
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 26.46
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 26.27
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 26.27
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 26.27
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 25.98
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 25.97
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 25.89
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 25.89
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 25.86
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 25.86
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 25.79
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 25.73
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 25.59
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 25.53
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 25.53
Regulation of Lipids is Central to Replicative Senescence 25.51
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 25.47
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 25.44
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 25.19
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 25.11
Molecular Mechanisms of Endothelial Hyperpermeability 25.08
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 25.04
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 24.83
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 24.7
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 24.63
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 24.54
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 24.54
HNRNPL and its RNA Targets in Prostate Cancer 24.34
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 24.34
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 24.33
Sensing self and nonself circular RNAs 24.16
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 24.12
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 24.12
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 24.11
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 24.09
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 24.09
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 24.01
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 24.0
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 23.88
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 23.82
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 23.72
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 23.7
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 23.59
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 23.56
TCF7L1 knockdown in pancreatic cancer 23.41
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 23.38
RNA Sequencing of three pairs of gastric cancer 23.27
Functional role of SLIT2 and ROBO1 in trophoblasts 23.16
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 23.14
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 23.14
circRNA profile in hypopharyngeal cancer 23.05
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 23.04
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 23.04
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 22.96
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 22.92
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 22.9
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 22.73
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 22.68
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 22.64
KLF6-dependent transcription in renal cancer cells 22.61
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 22.57
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 22.48
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 22.17
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 22.17
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 22.17
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 22.03
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 22.02
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 22.02
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 21.92
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 21.91
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 21.91
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 21.9
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 21.87
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 21.86
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 21.83
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 21.82
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 21.79
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 21.75
Differentially expressed genes post knock down of lincDUSP26 21.56
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 21.47
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 21.46
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 21.43
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 21.32
Spliceosomal disruption of the non-canonical BAF complex in cancer 21.32
circNFIB suppresses lymphatic metastasis of pancreatic cancer 21.26
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 21.18
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 21.14
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 21.14
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 21.13
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 21.12
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 21.1
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 20.97
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 20.97
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 20.9
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 20.88
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 20.82
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 20.82
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 20.81
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 20.78
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 20.7
Characterization of the Merkel cell carcinoma miRNome 20.7
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 20.67
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 20.67
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 20.65
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 20.56
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 20.53
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 20.2
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 20.1
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 20.1
snRNAs as regulators of alternative splicing 19.88
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 19.76
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 19.76
RNA sequencing of mechanically strained NHEKs and control NHEKs 19.76
Toxoplasma gondii infection of human retinal pigment epithelial cells 19.68
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 19.65
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 19.57
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 19.53
Transcriptomic profile of human embryonic renal corpuscles 19.26
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 19.25
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 19.25
ARS2 is a general suppressor of pervasive transcription [RNAseq] 19.19
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 19.11
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 19.11
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 18.99
Effect of BMP inhibition or stimulation of primary human keratinocytes 18.82
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 18.82
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 18.74
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 18.72
Gene profiling of human adult and pediatric liver cancer cells 18.71
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 18.71
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 18.36
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 18.3
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 18.21
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 18.13
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 18.04
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 17.99
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 17.79
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 17.76
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 17.61
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 17.61
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 17.61
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 17.54
Epigenome regulation during epidermal lineage commitment 17.53
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 17.4
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 17.4
Gene expression alterations of pancreatic intraepithlial neoplasia 17.34
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 17.34
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 17.32
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 17.11
The landscape of alternative splicing in aggressive prostate cancers 17.1
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 16.96
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 16.78
Genome-wide identification of cancer-specific alternative splicing in circRNA 16.53
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 16.51
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 16.47
RNA-seq analysis and shRNA screen of breast cancer 16.22
RNA-seq analysis of breast cancer 16.22
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 15.99
Gene expression profiling of papillary thyroid cancer from central and invasive regions 15.67
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 15.52
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 15.31
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 15.28
Selective suppression of endothelial cytokine production by progesterone receptor 15.28
m6A-dependent regulation of messenger RNA stability 15.25
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 15.21
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 15.1
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 15.01
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 15.01
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 14.88
RNA seq_PDX2_SHP099 14.84
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 14.75
RNA-seq of MDA-MB-231 cells with TET1 knockout 14.64
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 14.5
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 14.5
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 14.44
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 14.31
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 14.28
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 14.2
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 13.98
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 13.94
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 13.92
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 13.59
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 13.39
Argonaute proteins couple chromatin silencing to alternative splicing 13.39
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 12.77
Epigenome regulation during epidermal lineage commitment [RNA-seq] 12.61
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 12.39
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 12.25
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 12.13
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 12.13
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 11.88
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 11.81
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 11.75
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 11.75
UBC9 knockdown in bladder cancer T24 cell lines 11.38
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 11.32
Transcriptomic analysis of LSD1 11.32
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 11.26
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 11.0
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 11.0
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 10.79
A sister of NANOG regulates genes expressed in pre-implantation human development 10.73
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 10.53
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 10.49
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 10.49
Genome-wide discovery of human splicing branchpoints 10.41
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 10.41
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 10.35
Transcriptome analysis of human lung epithelial cells 10.27
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 10.25
The effect of Abl kinases on non-small cell carcinoma global transcriptome 10.06
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 10.01
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 9.86
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 9.82
Transcriptome-wide modulation of splicing by the exon junction complex 9.32
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 9.24
miR-93 Targets in Human Endothelial Cells 9.17
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 9.03
Expression charcaterization of an internal protocol developed to differentiate RPE cells 9.02
Gene expression analysis of human liver progenitor-like cells in culture 8.92
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 8.87
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 8.17
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 8.15
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 8.14
mRNA differential expression analysis in a human ex vivo model of chronic wounds 8.04
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 8.0
HNRNPM-regulated splicing dependencies in prostate cancer 8.0
Functional astrocytes differentiated from hiPSCs 7.92
Changes in human endometrial gland transcriptome over the window of implantation 7.82
circRNA-sequencing 7.73
CDK12 mediated transcriptional regulation in U2OS cells 7.71
Genome-wide discovery of human splicing branchpoints [RNAse] 7.71
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 7.6
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 7.53
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 7.33
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 7.33
Disruption of GRIN2B impairs differentiation in human neurons 7.33
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.23
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 7.02
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 6.97
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 6.95
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 6.77
Transcriptome-wide response to synthetic chromatin protein PcTF 6.58
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 6.45
Effects of transcription on genome - nuclear lamina interactions 6.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 6.07
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.02
Retinoic acid suppresses MYB in adenoid cystic carcinoma 5.99
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 5.99
Comparison of microRNA Profiling Platforms 5.97
Comparison of microRNA Profiling Platforms (HTS) 5.97
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.63
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 5.58
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 5.29
HEK293 Heat-shock experiment 5.28
RNAseq of Breast cancer PDX samples 5.25
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.23
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 5.13
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 5.13
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 4.41
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.23
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.23
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 4.05
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 4.02
RNA-seq of IL-4 stimulated human keratinocytes 3.94
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 3.71
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.68
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 3.6
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 3.6
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.42
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.42
Transcriptomic profiling of human peripheral blood-derived mast cells 3.34
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 3.34
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.97
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.96
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 2.96
RNA expression profiles comparing primary and omental ovarian carcinoma samples 2.9
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 2.86
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 2.81
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 2.81
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 2.79
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.78
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 2.78
Gene expression of collecting duct carcinoma of the kidney 2.73
Identification of long noncoding RNAs regulated by p53 2.72
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 2.67
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.63
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 2.52
BASP1 modifies the Tamoxifen response 2.43
RNA-seq identifies novel lncRNAs involved in vascular smooth muscle cell proliferation 2.41
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.35
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.26
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.22
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.22
Gene expression profile of CRC-derived HILEC 2.18
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 2.04
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 2.01
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 1.87
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.8
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.65
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.64
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.39
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 1.37
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 1.02
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 1.0
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.99
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 0.98
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 0.98
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.88
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.81
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.81
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 0.8
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.76
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.74
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 0.62
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.58
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.5
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.37
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.36
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.33
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.3
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.19
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.19
Identification of the role of polydom in neurofibromas 0.19
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.18
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.17
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.14
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.14
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation